QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)
QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)
QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)
QQQ   395.52 (+0.85%)
AAPL   193.18 (-1.29%)
MSFT   371.30 (-0.78%)
META   325.28 (-2.24%)
GOOGL   133.29 (-1.26%)
AMZN   145.89 (-1.04%)
TSLA   239.74 (-1.68%)
NVDA   466.27 (-1.85%)
NIO   7.68 (+4.07%)
BABA   71.37 (-1.07%)
AMD   134.41 (+4.26%)
T   16.62 (-1.77%)
F   11.07 (+0.54%)
MU   77.79 (+3.78%)
CGC   0.73 (-8.34%)
GE   120.28 (-0.26%)
DIS   92.20 (-0.67%)
AMC   7.11 (+2.60%)
PFE   28.64 (-0.49%)
PYPL   59.04 (+0.17%)
XOM   99.62 (+0.07%)

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) Price, Holdings, & News

$19.39
+0.05 (+0.26%)
(As of 05:07 PM ET)
Compare
Today's Range
$19.30
$19.45
50-Day Range
$19.34
$21.27
52-Week Range
$17.70
$21.64
Volume
201,061 shs
Average Volume
418,782 shs
Market Capitalization
$230.74 million
Assets Under Management
$278.70 million
Dividend Yield
1.08%
Net Expense Ratio
1.54%
BTAL stock logo

About AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

BTAL Stock Price History

BTAL ETF News Headlines

BTAL: A Smart Way To Hedge The Market
Vanguard Market Neutral Fund;Investor
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
AQR Equity Market Neutral Fund;R6
See More Headlines
Receive BTAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AGF U.S. Market Neutral Anti-Beta Fund and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
AGF Investments
Fund Name
AGF U.S. Market Neutral Anti-Beta Fund
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:BTAL
Inception Date
9/13/2011
Fund Manager
William DeRoche, Philip Lee, Josh Belko
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Long/Short
Development Level
Developed Markets
Region
North America
Number of Holdings
585

Fund Statistics

Assets Under Management
$278.70 million
Average Daily Volume
$532,898.70
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Chase Bank, N.A.
Advisor
AGF Investments LLC
Custodian
J.P. Morgan Chase Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
62
Put Options
1
Call Options
61
Short Interest
9,500 shs

Miscellaneous

Beta
-0.51
Creation Unit
50,000
Creation Fee
$1,500.00
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

AGF U.S. Market Neutral Anti-Beta Fund Expenses

TypeBTALLong/Short ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.45%0.82%0.53%0.50%0.50%
Other Expenses1.61%2.04%0.54%0.64%0.57%
Total Expense2.06%2.16%0.69%0.73%0.69%
Fee Waiver-0.52%-2.54%-0.54%-0.69%-0.57%
Net Expense1.54%1.02%0.60%0.57%0.57%

AGF U.S. Market Neutral Anti-Beta Fund (BTAL) Holdings & Exposure

BTAL Sector Exposure

BTAL Industry Exposure















BTAL ETF - Frequently Asked Questions

How have BTAL shares performed in 2023?

AGF U.S. Market Neutral Anti-Beta Fund's stock was trading at $21.21 on January 1st, 2023. Since then, BTAL stock has decreased by 8.6% and is now trading at $19.39.
View the best growth stocks for 2023 here
.

What does BTAL invest in?

AGF U.S. Market Neutral Anti-Beta Fund is a equity fund issued by AGF Investments. BTAL focuses on long/short investments. The fund's investments total to approximately $278.70 million assets under management.

What stocks does AGF U.S. Market Neutral Anti-Beta Fund hold?
What is the management fee for AGF U.S. Market Neutral Anti-Beta Fund?

AGF U.S. Market Neutral Anti-Beta Fund's management fee is 0.45% and has other expenses of 1.61%. However, BTAL has a fee waiver of -0.52% to reimburse the expenses. The net expense ratio for BTAL is 1.54%.

What other stocks do shareholders of AGF U.S. Market Neutral Anti-Beta Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AGF U.S. Market Neutral Anti-Beta Fund investors own include Ajinomoto (AJINY), Advanced Energy Industries (AEIS), Autodesk (ADSK), Koninklijke Ahold Delhaize (ADRNY), Accenture (ACN), American Campus Communities (ACC), Abbott Laboratories (ABT), AbbVie (ABBV), AAON (AAON).

Who are AGF U.S. Market Neutral Anti-Beta Fund's major shareholders?

AGF U.S. Market Neutral Anti-Beta Fund's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Triumph Capital Management (0.45%), Worth Asset Management LLC (0.34%) and Cambridge Investment Research Advisors Inc. (0.34%).

How do I buy shares of AGF U.S. Market Neutral Anti-Beta Fund?

Shares of BTAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEARCA:BTAL) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -